Publication | Closed Access

Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis

AllergyAtopic DermatitisAllergy MedicineMedicineImmunologySkin AllergyClinical DermatologyDermatologyIntravenous InfusionsImmunotherapyDrug AllergyJapanese Patients